Grissinger Michael 4
4 · Aprea Therapeutics, Inc. · Filed Jun 21, 2024
Insider Transaction Report
Form 4
Grissinger Michael
Director
Transactions
- Award
Common Stock
2024-06-20+1,045→ 1,844 total - Award
Stock Options (Right to Buy)
2024-06-20+4,185→ 4,185 totalExercise: $4.07Exp: 2034-06-20→ Common Stock (4,185 underlying)
Footnotes (2)
- [F1]These shares represent restricted stock units which were granted on June 20, 2024, and which will vest and be settled in common stock on June 20, 2025, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.
- [F2]The option vests in full on June 20, 2025, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.